Co-occurrence of pain symptoms and somatosensory sensitivity in burning mouth syndrome: a systematic review
2016 - Moisset X,Calbacho V,Torres P,Gremeau-Richard C,Dallel R PloS One n°11 - x
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study
2016 - Barbin L,Rousseau C,Jousset N,Casey R,Debouverie M,Vukusic S,De-Sèze J,Brassat D,Wiertlewski S, Brochet B, PelletierJ,Vermersch P,Edan G,Lebrun-Frenay C,Clavelou P,Thouvenot E,Camdessanché JP,Tourbah A,Stankoff B,Al Khedr A,Cabre P,Papeix C,Berger E,Heinzlef O,Debroucker T,Moreau T,GoutO,Bourre B,Créange A,Labauge P,Magy L,Defer G,FoucherY,Laplaud DA;CFSEP and OFSEP groups Neurology n°86(8) - pp 771/778.
Effects of glia metabolism inhibition on nociceptive behavioral testing in rats
2016 - Lefèvre Y,Amadio A,Vincent P,Descheemaeker A,Oliet SH,Dallel R,Voisin DL Data Brief n°7 - pp 372/375
Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study
2016 - Peyro Saint Paul L,Creveuil C,Heinzlef O,De Seze J,Vermersch P,Castelnovo G,Cabre P,Debouverie M,Brochet B,Dupuy B,Lebiez P,Sartori É,Clavelou P,Brassat D,Lebrun-Frenay C,Daplaud D,Pelletier J,Coman I,Hautecoeur P,Tourbah A,Defer G J Neurol Sci n°363 - pp 69/76
French Guidelines For the Emergency Management of Headaches
2016 - Moisset X,Mawet J,Guegan-Massardier E,Bozzolo E,Gilard V,Tollard E,Feraud T,Noëlle B,Rondet C,Donnet A Rev Neurol n°172 - pp 350/360
Geographical Heterogeneity of Multiple Sclerosis Prevalence in France
2016 - Pivot D,Debouverie M,Grzebyk M,Brassat D,Clanet M,Clavelou P,Confavreux C,Edan G,Leray E,Moreau T,Vukusic S,Hédelin G,Guillemin F PloS One n°11(12) - e0167556
Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study
2016 - Moisset X,Cornut-Chauvinc C,Clavelou P,Pereira B,Rouvet C,Dallel R,Guy N Palliat Med n°30(5) - pp 486/494
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study
2016 - Tourbah A,Lebrun-Frenay C,Edan G,Clanet M,Papeix C,Vukusic S,De Sèze J,Debouverie M,Gout O,Clavelou P,Defer G,Laplaud DA,Moreau T,Labauge P,Brochet B,Sedel F, Pelletier J; MS-SPI study group. Mult Scler n°22(13) - pp 1719/1731
Opioid use for the management of chronic non-cancer pain: French guidelines
2016 - Moisset X,Martinez V Rev Neurol n°172 - pp 337/338
Phloroglucinol protects retinal pigment epithelium and photoreceptor against all-trans-retinal-induced toxicity and inhibits A2E formation
2016 - Cia D,Cubizolle A,Crauste C,Jacquemot N,Guillou L,Vigor C,Angebault C,Hamel C,Vercauteren J,Brabet P J Cell Mol Med n°20 - pp 1651-63
Protein kinase Cγ Interneurons Mediates C-Fiber-Induced orofacial secondary static mechanical allodynia, but not C-fiber induced nociceptive behavior
2016 - Peirs C,Bourgois N,Artola A,Dallel R Anesthesiology n°124(5) - pp 1136/1152
Relationship between adaptation and cardiovascular response to tonic cold and heat pain Adaptability to tonic pain and cardiovascular responses
2016 - Devoize L,Chalaye P,Lafrenaye S,Marchand S,Dallel R Eur J Pain n°20(5) - pp 731/741
Use of strong opioids in chronic non-cancer pain in adults. Evidence-based recommendations from the French Society for the Study and Treatment of Pain
2016 - Moisset X,Trouvin AP,Tran VT,Authier N,Vergne-Salle P,Piano V,Martinez V Press Med n°45 - pp 447/462
Validation of a noninvasive test routinely used in otology for the diagnosis of cerebrospinal fluid shunt malfunction in patients with normal pressure hydrocephalus
2016 - Sakka L,Chomicki A,Gabrillargues J,Khalil T,Chazal J,Avan P J Neurosurg n°124(2) - pp 342-349
Who Performs Lumbar Puncture, How Many Do They Perform, How and Why? A Retrospective Study of 6,594 Cases.
2016 - Moisset X,Ruet A,Brochet B,Planche V,Jaffeux P,Gilleron V,Ong N,Clavelou P Eur Neurol n°76 - pp 8/11
Agomelatine: a new opportunity to reduce neuropathic pain. Preclinical evidence.
2016 - Chenaf C1,Chapuy E,Libert F,Marchand F,Courteix C,Bertrand M,Gabriel C,Mocaër E,Eschalier A,Authier N pain n°158 - pp 149.160
Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain.
2016 - Diochot S,Alloui A,Rodrigues P,Dauvois M,Friend V,Aissouni Y,Eschalier A,Lingueglia E,Baron A Pain n°157(3) - pp 552-559
Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.
2016 - Kerckhove N, Mallet C, Pereira B, Chenaf C, Duale C,Dubray C, Eschalier A BMJ Open n°6 - ONLINE
Codeine Shopping Behavior in a Retrospective Cohort of Chronic Noncancer Pain Patients: Incidence and Risk Factors
2016 - Chenaf C,Kabore JL,Delorme J,Pereira B,Mulliez A,Roche L,eschalier A,Delage N,Authier N J Pain n°16 - S1526-590
Comparative effects of α2δ-1 ligands in mouse models of colonic hypersensitivity.
2016 - Meleine M,Boudieu L,Gelot A,Muller E,Lashermes A,Matricon J,Silberberg C,Theodorou V,eschalier A,Ardid D,Carvalho FA World J Gastroenterol n°22(31) - pp 7111-7123